Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT03418532 |
Title | MP0250 DARPin Protein Plus Osimertinib in Patients With EGFR-mutated NSCLC |
Recruitment | Terminated |
Gender | both |
Phase | Phase Ib/II |
Variant Requirements | No |
Sponsors | Molecular Partners AG |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | USA |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
Scottsdale Healthcare Hospitals | Scottsdale | Arizona | 85258 | United States | Details | |
City of Hope - Comprehensive Cancer Center | Duarte | California | 91010 | United States | Details | |
University of California | San Diego | California | 92093 | United States | Details | |
UCLA Medical Center | Santa Monica | California | 90404 | United States | Details | |
Georgetown University | Washington | District of Columbia | 20057 | United States | Details | |
Florida Hospital | Orlando | Florida | 32803 | United States | Details | |
Duke Cancer Institute | Durham | North Carolina | 27710 | United States | Details | |
Tennessee Oncology | Nashville | Tennessee | 37203 | United States | Details | |
UT Southwestern Medical Center | Dallas | Texas | 75390 | United States | Details | |
Oncology Consultants | Houston | Texas | 77030 | United States | Details |